Medstone to Discuss Recent FDA Approval of Gallstone Treatment at Discovery Expo 2000.Business Editors/Health & Medical Writers Discovery Expo Fall 2000 ALISO VIEJO, Calif.--(BUSINESS WIRE)--Oct. 4, 2000 Medstone International Inc. (Nasdaq:MEDS meds A popular term for physician-prescribed medications ) is scheduled to discuss recent FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval of the company's proprietary gallstone gallstone: see gall bladder. gallstone Mass of crystallized substances that forms in the gallbladder. The most common type occurs when the liver secretes bile with too much cholesterol to stay in solution. treatment during the Discovery Expo 2000 on Oct. 23, in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . Medstone International designs, manufactures and markets the Medstone STS (Synchronous Transport Signal) The electrical equivalent of the SONET optical signal. In SDH, the European counterpart of SONET, STS is known as STM (Synchronous Transport Module). Shockwave Therapy System for the non-invasive disintegration of kidney stones. The Food and Drug Administration recently approved Medstone's request to use that same system, in tandem with medication, for the treatment of gallstones Gallstones Definition A gallstone is a solid crystal deposit that forms in the gallbladder, which is a pear-shaped organ that stores bile salts until they are needed to help digest fatty foods. . An estimated 25 million Americans suffer from gallstones. The new gallstone treatment combines Medstone's shockwave (lithotripsy) technology with short-term use of Actigall, a gallstone-dissolving drug made by Novartis Pharma AG (NYSE NYSE See: New York Stock Exchange :NVS). Clinical studies have indicated the combination therapy can speed up clearance of gallstones and result in higher success rates compared with drug therapy alone in certain patients. Discovery Expo 2000 will bring together undiscovered companies and high-profile growth fund managers, analysts, stockbrokers and investors in a one-day event. The Expo runs from noon to 7 p.m. on Monday, Oct. 23, at the Hilton New York on 6th Avenue at 53rd Street in New York City. Additional information on the event is available at the Discovery Web site, www.w3otc.com. About Medstone International Medstone is the leading distributor, manufacturer and fee-per-procedure service provider of lithotripters in the United States. Lithotripsy is a non-invasive, cost-effective and proven treatment that uses shock waves to break down kidney stones and gallstones. Medstone manufactures its extracorporeal shock wave lithotripters for sale to third parties and use within its own shared services program. In addition, it manufactures and distributes urology tables and a broad line of X-ray equipment. For more information, visit the company's Web site at www.medstone.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion